Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. Micropump is a microparticulate system that allows the development of modified and/or controlled release of solid, oral dosage formulations of drugs. LiquiTime uses Micropump's competitive advantages to allow development of modified/controlled release liquid suspension formulations. TriggerLock is a drug delivery platform with the potential to provide a controlled release of opioid analgesics. Medusa is a hydrogel depot technology that allows a delivery, resulting in treatment adherence.
The Company offers its products in various categories, such as hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Karbinal ER, a Histamine 1 (H1) receptor antagonist (antihistamine) indicated for children over two years of age. Karbinal ER provides physicians to use treatment option for children with seasonal and perennial allergic rhinitis that need symptomatic relief for runny nose, sneezing, and itchy skin. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.
The Company competes with Alkermes plc, COSMO Pharmaceuticals SpA, Depomed, Inc., Durect Corp., Supernus Pharmaceuticals, Inc., Veloxis Pharmaceuticals A/S, Neos Therapeutics, Inc., Tris Pharma, Inc., Acura Pharmaceuticals, Inc., Altus Formulation, Cephalon, Collegium Pharmaceutical, Inc., Egalet Corporation, Elite Pharmaceuticals, Inc., Ethypharm, Grunenthal Group, Intellipharmaceutics International, Inc., QRx Pharma, Ltd., KemPharm, Inc., Biodel Inc., Debiopharm Group, LG Life Sciences, InnoCore Pharmaceuticals, Marina Biotech, Inc., MedinCell SA, Dr. Reddy's, Onxeo, Pacira Pharmaceuticals, Inc., Midatech, REcoly N.V., Soligenix, Inc., Surmodics, Inc. and Xenetic Biosciences plc.
Blanchardstown Corporate Park, D
The company trades on NASDAQ exchange. The company headquarter is located in France. The company was established in the 1990.| Ticker | AVDL |
| Long Name | Avadel Pharmaceuticals plc |
| Short Name | Avadel Pharma |